The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Adults With Prediabetes or Type 2 Diabetes

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT05844644

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Golo (from the registry)
Registry
  • NCT NCT05844644
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05844644. Allocation not applicable; no masking; primary purpose treatment. Start 2023-04-20 (actual); primary completion 2024-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Adults With Prediabetes or Type 2 Diabetes
Condition
Obese
Condition
Overweight
Condition
Prediabetes
Intervention (Dietary supplement)
Release
Lead sponsor
Golo (class: industry)
Collaborator
KGK Science Inc. (class: industry)

Record details

Record id
cardio:ct-nct05844644
Content hash
45b6596e825cbf7ad01804358c585e19c6f2733233e8f7fbb697361d6bee8441